Literature DB >> 9021736

Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans.

D W Knapp1, D J Waters.   

Abstract

It has been said that "dog is man's best friend'. Comparative oncologists are demonstrating that pet dogs could hold the keys for advances in cancer treatment in people. Specific types of cancer that arise spontaneously in pet dogs could serve as important models of human cancer, having much greater similarity to their counterparts in humans than many currently used experimentally induced tumor models. In vivo models that are relevant to human cancer are greatly needed, particularly for evaluating new strategies for cancer therapy, such as augmentation of the immune system or blockade of the metastatic cascade. In addition, pet dogs could also be used to identify environmental carcinogens by acting as sentinels of cancer induced by these toxins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9021736     DOI: 10.1016/s1357-4310(96)20031-0

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  22 in total

1.  Allogeneic astrocytoma in immune competent dogs.

Authors:  M E Berens; A Giese; J R Shapiro; S W Coons
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

Review 2.  How can grafted breast cancer models be optimized?

Authors:  Séverine Mollard; Yoanne Mousseau; Yasser Baaj; Laurence Richard; Jeanne Cook-Moreau; Jacques Monteil; Benoît Funalot; Franck G Sturtz
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

3.  Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology.

Authors:  L Nasir; P Devlin; T Mckevitt; G Rutteman; D J Argyle
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

4.  Guiding the optimal translation of new cancer treatments from canine to human cancer patients.

Authors:  Chand Khanna; Cheryl London; David Vail; Christina Mazcko; Steven Hirschfeld
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

5.  Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs.

Authors:  T J Jónasdóttir; C S Mellersh; L Moe; R Heggebø; H Gamlem; E A Ostrander; F Lingaas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

6.  Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo.

Authors:  Maria Cekanova; Md Jashim Uddin; Joseph W Bartges; Amanda Callens; Alfred M Legendre; Kusum Rathore; Laura Wright; Amanda Carter; Lawrence J Marnett
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26

7.  A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer.

Authors:  Dorothy Cimino Brown; Raymond Boston; James C Coyne; John T Farrar
Journal:  Pain Med       Date:  2008-09-24       Impact factor: 3.750

8.  Oral malignant melanomas and other head and neck neoplasms in Danish dogs--data from the Danish Veterinary Cancer Registry.

Authors:  Louise B Brønden; Thomas Eriksen; Annemarie T Kristensen
Journal:  Acta Vet Scand       Date:  2009-12-18       Impact factor: 1.695

9.  Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine model.

Authors:  Maria Cekanova; Md Jashim Uddin; Alfred M Legendre; Gina Galyon; Joseph W Bartges; Amanda Callens; Tomas Martin-Jimenez; Lawrence J Marnett
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

10.  Comparative expression pathway analysis of human and canine mammary tumors.

Authors:  Paolo Uva; Luigi Aurisicchio; James Watters; Andrey Loboda; Amit Kulkarni; John Castle; Fabio Palombo; Valentina Viti; Giuseppe Mesiti; Valentina Zappulli; Laura Marconato; Francesca Abramo; Gennaro Ciliberto; Armin Lahm; Nicola La Monica; Emanuele de Rinaldis
Journal:  BMC Genomics       Date:  2009-03-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.